晚期慢性肾病药物市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00013768
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 194
Buy Now

2019年晚期慢性肾病药物市场价值为46.800亿美元,预计到2027年将达到110.969亿美元;预计2020年至2027年复合年增长率为11.6%。

晚期肾病,也称为终末期肾病,发生在慢性肾病时疾病(肾功能逐渐丧失)达到晚期状态。在终末期肾病中,肾脏不再能够正常工作来满足身体的需要。在这个晚期阶段,肾脏失去了所有有效运作的能力,最终需要透析或肾移植来挽救生命。慢性肾病的高患病率和晚期慢性肾病药物的优惠报销政策是推动市场增长的主要因素。然而,慢性肾脏病诊断的延迟预计将在预测期内在一定程度上阻碍市场的增长。

晚期慢性肾脏病的利润丰厚的地区肾病药物市场


市场洞察

疾病高患病率导致慢性肾脏病

慢性肾脏病 (CKD) 是一种常见且危及生命的疾病,影响全球十分之一的人。它影响了超过 2600 万美国人以及全球数百万人。 2015 年至 2017 年间,高血压和糖尿病是导致 75% 肾衰竭病例的两个主要原因。47% 的新发终末期肾病 (ESKD) 患者初步诊断为糖尿病,而 29% 的新发终末期肾病 (ESKD) 患者初步诊断为糖尿病。肾脏疾病患者的初步诊断为高血压。此外,根据拜耳的新闻稿,美国约有 2900 万人患有 2 型糖尿病,其中 40% 的人将在未来一年患上 CKD。

根据 CDC 数据,三分之一的糖尿病成人和五分之一的高血压成人可能患有慢性肾病。根据美国糖尿病协会 (ADA) 的数据,2015 年,美国有 3030 万人患有糖尿病。据美国疾病控制和预防中心称,2014年,美国约有118,000人开始接受终末期肾病的治疗,随着越来越多的人意识到这种情况,接受治疗的人数预计还会增加。此外,CDC指出,约96%的肾损伤患者不知道自己患有慢性肾病,这预示着慢性肾病药物后期的潜在市场前景。这些因素预计将在预测期内促进市场增长。

根据国家肾脏基金会的数据,慢性肾病导致的死亡人数比前列腺癌或乳腺癌还要多。这是人们未被充分认识的紧急健康状况。据估计,它影响了美国 2600 万人(占成年人口的 15%;超过七分之一的成年人)。三分之一的美国成年人(约 8000 万人)面临 CKD 的风险。慢性肾病在女性中比男性更常见。它是美国第九大死因。肾小球肾炎(损害肾脏过滤单位的疾病);遗传性疾病,例如多囊肾病;胎儿发育过程中的畸形;狼疮和其他免疫疾病;肾结石或前列腺肥大等阻塞;反复尿路感染是可能导致 ESKD 的其他疾病。

引入新的临床前模型以改进目标验证并了解疾病发展

公司通常采用产品发布和扩张策略来扩大其全球足迹、满足不断增长的需求并增加其产品组合。

晚期慢性肾病药物市场的主要参与者采取了产品创新策略,以满足全球不断变化的客户需求,这也使参与者能够在全球范围内保持其品牌声誉。

p>

按产品类型

  • 拟钙剂
  • 维生素 D
  • 甾醇
  • < li>钾结合剂
  • 钙基磷酸盐结合剂

按适应症

  • 晚期慢性肾病引起的甲状旁腺功能亢进
  • 晚期慢性肾脏病引起的高磷血症
  • 晚期慢性肾脏病引起的高钾血症

按分销渠道划分

  • 医院药房
  • 在线药店
  • 零售药店

按地理位置

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
  • 亚太地区 (APAC)
    • 中国
  • 亚太地区 (APAC)
    • 中国
    • li>
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
  • 南美洲和中美洲 (SCAM )
    • 巴西
    • 阿根廷

公司简介

  • 艾伯维公司
  • 安进
  • 阿斯利康
  • 赛诺菲公司
  • 协和麒麟株式会社
  • 武田制药有限公司
  • 安斯泰来制药公司
  • 拜耳股份公司
  • Vifor Pharma Management Ltd.
  • Akebia Therapeutics,公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is late stage chronic kidney disease drugs?

Late-stage renal disease, also called end-stage kidney disease, occurs when chronic kidney disease (the gradual loss of kidney function) reaches an advanced state. In end-stage renal disease, kidneys are no longer able to work as they should to meet the body's needs. At this advanced stage of kidney disease, the kidneys have lost nearly all their ability to do their job effectively, and eventually dialysis or a kidney transplant is needed to live. Few classes of drugs are specifically used for the treatment of late stage chronic kidney disease are known as late stage chronic kidney disease drugs.

What are the driving factors for the late stage chronic kidney disease drugs market across the globe?

The factors that are driving growth of the market are high prevalence of diseases leading to chronic kidney diseases and favorable reimbursement policy for the late stage chronic kidney disease drugs are expected to boost the growth of the global late stage chronic kidney disease drugs market.

Who are the major players in the late stage chronic kidney disease drugs market?

The late stage chronic kidney disease drugs market majorly consists of the players such AbbVie Inc., Amgen, AstraZeneca, Sanofi, Kyowa Kirin Co., Ltd., Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Bayer AG, Vifor Pharma Management Ltd., and Akebia Drugs, Inc. among others.

The List of Companies - Late Stage Chronic Kidney Disease Drugs Market

  1. AbbVie Inc.
  2. Amgen
  3. AstraZeneca
  4. Sanofi
  5. Kyowa Kirin Co., Ltd.
  6. Takeda Pharmaceutical Company Limited
  7. Astellas Pharma Inc.
  8. Bayer AG
  9. Vifor Pharma Management Ltd.
  10. Akebia Drugs, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports